Authors: Halseth M, Mahoney R, Hsiou J, Jones HN, et al.
Year: 2024
Journal: Neuromuscular Disorders
Link: https://www.sciencedirect.com/science/article/pii/S0960896623008118
Summary:
Study investigating remotely administered inspiratory muscle training in patients with VCP multisystem proteinopathy, a rare neuromuscular disease causing progressive respiratory muscle weakness.
Key Findings:
- Remote IMT improved respiratory function in rare neuromuscular disease
- VCP multisystem proteinopathy causes progressive respiratory muscle weakness and early mortality from respiratory failure
- Weeks of inspiratory muscle training produced measurable improvements
- Remote administration feasible for patients with complex medical needs
- Demonstrates PrO2 applications beyond common pulmonary and cardiac conditions
- First study examining IMT in this rare disease population
Clinical Implications:
- IMT may benefit rare neuromuscular diseases with respiratory involvement
- Remote delivery enables treatment for homebound patients with complex needs
- Potential to delay respiratory failure progression
- Establishes proof-of-concept for other neuromuscular conditions
- Expands therapeutic applications of respiratory muscle training